Blog & Resources

By Kelly Bilodeau (Originally Published April 18th, 2024 on pharmavoice)

By Andrew "AJ" Mills (Originally Published March 24th, 2024 on pharmaphorum)

Embarking into the new frontier of clinical research, rare diseases, niche indications and limited resources for small study teams will increasingly become the norm. As challenges increase, AI will...

Everything about AI in Life Sciences, we learned in Kindergarten

A Reflection of 2023 in Clinical Research By Rohit Nambisan In many ways, 2023 was a banner year for patients – the FDA approved 55 new medications, the most in five years – including the first ...

During this presentation, hear industry leaders Alana Miller, Daniel Perez, and Rohit Nambisan explore innovative ways to leverage AI and ML technologies to optimize your study enrollment and ensure...

Introduction In Clinical Trials, buzzwords like "artificial intelligence," "machine learning," and "predictive analytics" are common industry terms that can be confusing without a comprehensive...

Imagine being able to predict the future of clinical trials. What if you could foresee the outcomes of your trials, understand the potential roadblocks, and strategize accordingly? On May 16, we took...

Investigating the truth behind a common industry myth that may help predict enrollment performance

Investigating the truth behind a common industry myth that informs enrollment decisions

Reimagining study management to preserve quality and choice

Lokavant’s mission is to leverage predictive analytics to effectively plan and execute trials.